Android app on Google Play

Goldman Sachs Downgrades Humana (HUM) to Sell

November 7, 2012 8:09 AM EST Send to a Friend
Get Alerts HUM Hot Sheet
Price: $118.80 +0.98%

Rating Summary:
    7 Buy, 11 Hold, 3 Sell

Rating Trend: = Flat

Today's Overall Ratings:
    Up: 43 | Down: 33 | New: 14
Trade HUM Now!
Join SI Premium – FREE
Goldman Sachs downgraded Humana (NYSE: HUM) from Neutral to Sell with a price target of $62.00 (from $77.00), suggesting 19% downside.

"With health reform now more likely to move ahead following the election outcome, we see greater downside risk to Medicare Advantage, which we estimate comprises over 70% of the HUM's earnings."

For an analyst ratings summary and ratings history on Humana click here. For more ratings news on Humana click here.

Shares of Humana closed at $76.16 yesterday.




You May Also Be Interested In


Related Categories

Downgrades

Related Entities

Goldman Sachs, Earnings

Add Your Comment